K. Floros

发表

Dual barrier InAlN/AlGaN/GaN‐on‐silicon high‐electron‐mobility transistors with Pt‐ and Ni‐based gate stacks

D. Wallis, I. Thayne, C. Humphreys, 2017 .

Catastrophic ATP loss underlies a metabolic combination therapy tailored for MYCN-amplified neuroblastoma

Patricia Greninger, C. Benes, B. Hu, 2021, Proceedings of the National Academy of Sciences.

Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM

B. Bernstein, Y. Drier, L. Sequist, 2017, Clinical Cancer Research.

Investigating New Mechanisms of Acquired Resistance to Targeted Therapies: If You Hit Them Harder, Do They Get Up Differently?

A. Faber, A. Hata, K. Floros, 2020, Cancer research.

MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis

Krista M. Powell, S. Ramamoorthy, M. Dozmorov, 2021, Cancer Research.

Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.

A. Scorilas, N. Tosic, M. Čolović, 2012, Clinical biochemistry.

1 Title : The Ewing family of tumors rely on BCL-2 and BCL-X L to escape PARP inhibitor toxicity

C. Benes, J. Leverson, A. Faber, 2018 .

Genomic screening reveals UBA1 as a potent and druggable target in c-MYC-high TNBC models

C. Benes, B. Hu, J. Harrell, 2022, bioRxiv.

Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination

U. McDermott, M. Garnett, A. Dastur, 2016, Cancer cell.

Mitochondrial shape governs BAX-induced membrane permeabilization and apoptosis.

D. Newmeyer, J. Chipuk, Y. Kushnareva, 2015, Molecular cell.

MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma

M. Dozmorov, A. Faber, L. Cowart, 2022, Cell stress.

Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung Cancer.

M. Nishimura, S. Tomida, S. Yano, 2016, Cancer discovery.

Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma

Krista M. Powell, Patricia Greninger, C. Benes, 2018, Science Translational Medicine.

BAK/BAX activation and cytochrome c release assays using isolated mitochondria.

J. Chipuk, Thibaud T. Renault, K. Floros, 2013, Methods.

Molecular Response of HL‐60 Cells to Mitotic Inhibitors Vincristine and Taxol Visualized with Apoptosis‐Related Gene Expressions, Including the New Member BCL2L12

A. Scorilas, K. Floros, Hellinida Thomadaki, 2009, Annals of the New York Academy of Sciences.

The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment.

Jerry E. Chipuk, J. Chipuk, Rana Elkholi, 2011, Genes & cancer.

Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy

J. Arribas, C. Costa, H. Harada, 2018, Proceedings of the National Academy of Sciences.

The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity

Krista M. Powell, C. Benes, J. Leverson, 2018, Clinical Cancer Research.

Unmasking BCL-2 Addiction in Synovial Sarcoma by Overcoming Low NOXA

H. Harada, J. Leverson, M. Dozmorov, 2021, Cancers.

Sensitivity and Resistance to BH3 Mimetics in Cancer Therapy

H. Harada, A. Faber, K. Floros, 2018 .

Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression

Krista M. Powell, Patricia Greninger, C. Benes, 2017, Clinical Cancer Research.

Sensitization to the mitochondrial pathway of apoptosis augments melanoma tumor cell responses to conventional chemotherapeutic regimens

G. Belbin, S. Izadmehr, J. Chipuk, 2012, Cell Death and Disease.

Pharmacologic Inhibition of SHP2 Blocks Both PI3K and MEK Signaling in Low-epiregulin HNSCC via GAB1

Patricia Greninger, C. Benes, B. Hu, 2022, Cancer research communications.

Tracing the future of migrants’ labour relations. Experiences of institutionalised migrant precarity in Denmark and Greece

M. Jørgensen, K. Floros, 2020 .

Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors

M. Scaltriti, M. Dozmorov, A. Faber, 2021, Cell Death & Disease.

Migrants’ Entrapment in a ‘State of Expectancy’: Patterns of Im/mobility for Agricultural Workers in Manolada, Greece

M. Jørgensen, K. Floros, A. Kapsalis, 2020 .

Friday 24 July 2015

Heather K. Neilson, Stuart A. Sievers, W. Starbuck, 2015, Journal of Medical Radiation Sciences.

One gene to rule them all…and in the darkness bind them

A. Faber, K. Floros, 2018, Molecular & cellular oncology.

Hybrid Data-Driven Modeling Methodology for Fast and Accurate Transient Simulation of SiC MOSFETs

Jun Liang, Wenlong Ming, Peng Yang, 2021, IEEE Transactions on Power Electronics.

The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment.

J. Chipuk, K. Floros, R. Elkholi, 2011, Genes & cancer.

Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma

S. Radhakrishnan, Richard I. J. Kurupi, A. Banito, 2024, bioRxiv.

NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS Molecular Response of HL-60 Cells to Mitotic Inhibitors Vincristine and Taxol Visualized with Apoptosis-Related Gene Expressions, Including the New Member BCL2L12

A. Scorilas, K. Floros, Hellinida Thomadaki, 2009 .